Incyte Eulerpool Ziņas

Incyte Eulerpool News

Incyte Akciju Ziņas

Incyte tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Incyte ziņas mēs apkopojam šeit.

• 25. septembris ·

  Yahoo
  Incyte Gains 12.7% Year to Date: How Should You Play the Stock?
• 25. septembris ·

  Yahoo
  Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
• 25. septembris ·

  Business Wire
  Multiple Late-Breaking Data Presentations from Incyte?s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
• 24. septembris ·

  PR Newswire
  Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase
• 23. septembris ·

  SeekingAlpha
  Eliem Therapeutics: Recent Strategic Pipeline Restructuring
• 20. septembris ·

  SeekingAlpha
  Syndax Pharmaceuticals: Navigating Through A Pivotal Year
• 18. septembris ·

  Yahoo
  Incyte and Syndax Announce New England Journal of Medicine Publication of Data from Pivotal AGAVE-201 Trial of Niktimvo™ (axatilimab-csfr) in Chronic Graft-Versus-Host Disease
• 18. septembris ·

  Yahoo
  Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
• 18. septembris ·

  PR Newswire
  Incyte and Syndax Announce New England Journal of Medicine Publication of Data from Pivotal AGAVE-201 Trial of Niktimvo? (axatilimab-csfr) in Chronic Graft-Versus-Host Disease
• 18. septembris ·

  Yahoo
  Update: Truist Securities Downgrades Incyte to Hold From Buy, Cuts Price Target to $74 From $83